Pennsylvanian fungal technology firm Sylvan, a major grower of fresh mushrooms in the US, has recently retained investment bank Lane, Berry & Co Int to assist with an evaluation of strategic plans and business alternatives designed to enhance Sylvan's shareholder value. The action was recommended by a special committee of the board of directors, composed of the board's outside members, that was organised for the purpose of selecting an advisor.